An investigator-blind randomized controlled trial comparing effectiveness, safety of levocetirizine and bepotastine in chronic urticaria
Introduction: Chronic urticaria is common and distressing dermatosis where the search for newer agents with improved effectiveness and tolerability profile is a felt need. Bepotastine, a second-generation antihistamine, with added effect on suppression of eosinophil migration has a prospect in the m...
Saved in:
Main Authors: | Amrita Sil (Author), Sufiur Rahaman (Author), Nasiruddin Mondal (Author), Sk Shahriar Ahmed (Author), Dhiman Tarafdar (Author), Aparesh Chandra Patra (Author), Sudipta Roy (Author), Nilay Kanti Das (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A prospective, randomized, open-label, active-controlled study to compare the efficacy and safety of levocetirizine and bepotastine in chronic spontaneous urticaria
by: Gaurav Menghani, et al.
Published: (2023) -
Pharmacokinetic Modeling of Bepotastine for Determination of Optimal Dosage Regimen in Pediatric Patients with Allergic Rhinitis or Urticaria
by: Sukyong Yoon, et al.
Published: (2024) -
Comparison Of Levocetirizine And Cetirizine In Chronic Idiopathic Urticaria
by: Rathi Sanjay K
Published: (2004) -
Comparative efficacy of fexofenadine and levocetirizine in chronic idiopathic urticaria
by: Godse K, et al.
Published: (2007) -
Autologous serum therapy in chronic urticaria: A promising complement to antihistamines
by: Panchami Debbarman, et al.
Published: (2014)